4.3 Article

LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R)

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 215, Issue 1-2, Pages 36-42

Publisher

ELSEVIER
DOI: 10.1016/j.jneuroim.2009.07.016

Keywords

Chemokine; LTP; Hippocampus; Glutamate receptor; fEPSP; Adenosine receptor

Funding

  1. Ministero Universita & Ricerca scientifica
  2. Fondazione Cenci Bolognetti
  3. Ministero Salute (Ricerca finalizzata)
  4. Swedish Science Research Council

Ask authors/readers for more resources

We have examined how the chemokine fractalkine/CX(3)CL1 influences long-term potentiation (LTP) in CA1 mouse hippocampal slices. Field potentials (fEPSPs) were recorded upon electrical stimulation of Schaffer collaterals. It was found that application of CX(3)CL1 inhibits LTP when present during the critical induction period. LTP impairment (i) failed to occur in CX(3)CR1 deficient mice (CX3CR1GFP/GFP) and in the presence of okadaic acid (OA); (ii) required the activation of adenosine receptor 3 (A(3)R), since it was prevented in A(3)R-deficient mice or by MRS1523, a selective A(3)R antagonist. Together, these findings indicate that CX(3)CL1 inhibits hippocampal LTP through A(3)R activity. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available